Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Dose-volume relationship for laryngeal substructures and aspiration in patients with locally advanced head-and-neck cancer.

Petras KG, Rademaker AW, Refaat T, Choi M, Thomas TO, Pauloski BR, Mittal BB.

Radiat Oncol. 2019 Mar 18;14(1):49. doi: 10.1186/s13014-019-1247-7.

2.

Patterns of Failure and Survival Outcomes after Total Lymphoid Irradiation and High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Relapsed or Refractory Classical Hodgkin Lymphoma.

Paudel N, Schulze D, Gentzler RD, Evens AM, Helenowski I, Dillehay G, Frankfurt O, Mehta J, Donnelly ED, Gordon LI, Winter JN, Mittal BB.

Int J Radiat Oncol Biol Phys. 2019 Feb 11. pii: S0360-3016(19)30197-X. doi: 10.1016/j.ijrobp.2019.02.007. [Epub ahead of print]

PMID:
30763660
3.

DVH Analytics: A DVH database for clinicians and researchers.

Cutright D, Gopalakrishnan M, Roy A, Panchal A, Mittal BB.

J Appl Clin Med Phys. 2018 Sep;19(5):413-427. doi: 10.1002/acm2.12401. Epub 2018 Jul 21.

4.

NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.

Colevas AD, Yom SS, Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Eisele DW, Fenton M, Foote RL, Gilbert J, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Zhen W, Burns JL, Darlow SD.

J Natl Compr Canc Netw. 2018 May;16(5):479-490. doi: 10.6004/jnccn.2018.0026.

PMID:
29752322
5.

NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.

Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Gilbert J, Haddad RI, Hicks WL Jr, Hitchcock YJ, Jimeno A, Leizman D, Lydiatt WM, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD.

J Natl Compr Canc Netw. 2017 Jun;15(6):761-770. doi: 10.6004/jnccn.2017.0101.

PMID:
28596256
6.

Single Fraction Stereotactic Radiosurgery for Retreatment of Skull Base Recurrent Head and Neck Malignancies.

Patel RA, Lock D, Kim T, Samant S, Chandler JP, Mittal BB, Kruser TJ.

Cureus. 2017 May 1;9(5):e1206. doi: 10.7759/cureus.1206.

7.

Stereotactic radiosurgery for brain metastases from primary head and neck carcinomas: a retrospective analysis.

Patel RA, Bell JB, Kim T, Agulnik M, Chandler JP, Mittal BB, Kruser TJ.

J Neurooncol. 2017 Aug;134(1):197-203. doi: 10.1007/s11060-017-2509-6. Epub 2017 May 25.

PMID:
28547589
8.

Raynaud's of the tongue following chemoradiation for squamous cell carcinoma of the oropharynx.

Mittal A, Mittal BB.

Mol Clin Oncol. 2017 Feb;6(2):187-188. doi: 10.3892/mco.2016.1103. Epub 2016 Dec 7.

9.

Effects of Change in Tongue Pressure and Salivary Flow Rate on Swallow Efficiency Following Chemoradiation Treatment for Head and Neck Cancer.

Rogus-Pulia NM, Larson C, Mittal BB, Pierce M, Zecker S, Kennelty K, Kind A, Connor NP.

Dysphagia. 2016 Oct;31(5):687-96. doi: 10.1007/s00455-016-9733-7. Epub 2016 Aug 4.

10.

Single-Fraction Radiotherapy for CD30(+) Lymphoproliferative Disorders.

Gentile MS, Martinez-Escala ME, Thomas TO, Guitart J, Rosen S, Kuzel T, Mittal BB.

Biomed Res Int. 2015;2015:629587. doi: 10.1155/2015/629587. Epub 2015 Oct 4.

11.

Head and Neck Cancers, Version 1.2015.

Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Foote RL, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian N, Hughes M.

J Natl Compr Canc Netw. 2015 Jul;13(7):847-55; quiz 856.

12.

Brachial plexus dose tolerance in head and neck cancer patients treated with sequential intensity modulated radiation therapy.

Thomas TO, Refaat T, Choi M, Bacchus I, Sachdev S, Rademaker AW, Sathiaseelan V, Karagianis A, Mittal BB.

Radiat Oncol. 2015 Apr 18;10:94. doi: 10.1186/s13014-015-0409-5.

13.

Age most significant predictor of requiring enteral feeding in head-and-neck cancer patients.

Sachdev S, Refaat T, Bacchus ID, Sathiaseelan V, Mittal BB.

Radiat Oncol. 2015 Apr 18;10:93. doi: 10.1186/s13014-015-0408-6.

14.

Thyroid V50 Highly Predictive of Hypothyroidism in Head-and-Neck Cancer Patients Treated With Intensity-modulated Radiotherapy (IMRT).

Sachdev S, Refaat T, Bacchus ID, Sathiaseelan V, Mittal BB.

Am J Clin Oncol. 2017 Aug;40(4):413-417. doi: 10.1097/COC.0000000000000165.

PMID:
25503434
15.

Development of a standardized method for contouring the larynx and its substructures.

Choi M, Refaat T, Lester MS, Bacchus I, Rademaker AW, Mittal BB.

Radiat Oncol. 2014 Dec 11;9:285. doi: 10.1186/s13014-014-0285-4.

16.

Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology.

Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Schuller DE, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2014 Oct;12(10):1454-87.

17.

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer.

Cohen EE, Karrison TG, Kocherginsky M, Mueller J, Egan R, Huang CH, Brockstein BE, Agulnik MB, Mittal BB, Yunus F, Samant S, Raez LE, Mehra R, Kumar P, Ondrey F, Marchand P, Braegas B, Seiwert TY, Villaflor VM, Haraf DJ, Vokes EE.

J Clin Oncol. 2014 Sep 1;32(25):2735-43. doi: 10.1200/JCO.2013.54.6309. Epub 2014 Jul 21.

18.

Comparison of swallowing function after intensity-modulated radiation therapy and conventional radiotherapy for head and neck cancer.

Pauloski BR, Rademaker AW, Logemann JA, Discekici-Harris M, Mittal BB.

Head Neck. 2015 Nov;37(11):1575-82. doi: 10.1002/hed.23796. Epub 2014 Aug 1.

19.

Bolus effects on patient awareness of swallowing difficulty and swallow physiology after chemoradiation for head and neck cancer.

Rogus-Pulia NM, Pierce M, Mittal BB, Zecker SG, Logemann J.

Head Neck. 2015 Aug;37(8):1122-9. doi: 10.1002/hed.23720. Epub 2014 Aug 28.

PMID:
24841209
20.

Effect of induction chemotherapy on swallow physiology and saliva production in patients with head and neck cancer: a pilot study.

Mittal BB, Pauloski BR, Rademaker AW, Discekici-Harris M, Helenowski IB, Mellot A, Agulnik M, Logemann JA.

Head Neck. 2015 Apr;37(4):567-72. doi: 10.1002/hed.23635. Epub 2014 Apr 9.

21.

F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma.

Gentzler RD, Evens AM, Rademaker AW, Weitner BB, Mittal BB, Dillehay GL, Petrich AM, Altman JK, Frankfurt O, Variakojis D, Singhal S, Mehta J, Williams S, Kaminer L, Gordon LI, Winter JN.

Br J Haematol. 2014 Jun;165(6):793-800. doi: 10.1111/bjh.12824. Epub 2014 Mar 15.

PMID:
24628515
22.

Changes in swallowing physiology and patient perception of swallowing function following chemoradiation for head and neck cancer.

Rogus-Pulia NM, Pierce MC, Mittal BB, Zecker SG, Logemann JA.

Dysphagia. 2014 Apr;29(2):223-33. doi: 10.1007/s00455-013-9500-y. Epub 2014 Jan 9.

PMID:
24402239
23.

Burnout in United States academic chairs of radiation oncology programs.

Kusano AS, Thomas CR Jr, Bonner JA, DeWeese TL, Formenti SC, Hahn SM, Lawrence TS, Mittal BB.

Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):363-8. doi: 10.1016/j.ijrobp.2013.09.027. Epub 2013 Nov 1.

PMID:
24189126
24.

Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.

Refaat T, Choi M, Thomas TO, Bacchus I, Agulnik M, Pelzer HJ, Mellott AL, Rademaker AW, Liu D, Sathiaseelan V, Mittal BB.

Am J Clin Oncol. 2015 Dec;38(6):588-94. doi: 10.1097/COC.0000000000000001.

25.

Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines.

Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2013 Aug;11(8):917-23. Erratum in: J Natl Compr Canc Netw. 2013 Dec 1;11(12):1458.

PMID:
23946171
26.

Effect of recombinant human deoxyribonuclease on oropharyngeal secretions in patients with head-and-neck cancers treated with radiochemotherapy.

Mittal BB, Wang E, Sejpal S, Agulnik M, Mittal A, Harris K.

Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):282-9. doi: 10.1016/j.ijrobp.2013.06.002. Epub 2013 Aug 1.

PMID:
23910712
27.

Using intensity-modulated radiotherapy to spare the kidney in a patient with seminoma and a solitary kidney: a case report.

Choi M, Hayes JP, Mehta MP, Swisher A, Small W Jr, Mittal BB, MacVicar GR, Kalapurakal JA, Sejpal SV.

Tumori. 2013 Mar-Apr;99(2):e38-42. doi: 10.1700/1283.14205.

PMID:
23748827
28.

A comprehensive quality assurance program for personnel and procedures in radiation oncology: value of voluntary error reporting and checklists.

Kalapurakal JA, Zafirovski A, Smith J, Fisher P, Sathiaseelan V, Barnard C, Rademaker AW, Rave N, Mittal BB.

Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):241-8. doi: 10.1016/j.ijrobp.2013.02.003. Epub 2013 Apr 2.

PMID:
23561649
29.

Outcome of patients treated with a single-fraction dose of palliative radiation for cutaneous T-cell lymphoma.

Thomas TO, Agrawal P, Guitart J, Rosen ST, Rademaker AW, Querfeld C, Hayes JP, Kuzel TM, Mittal BB.

Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):747-53. doi: 10.1016/j.ijrobp.2012.05.034. Epub 2012 Jul 17.

PMID:
22818412
30.

Mucosal melanoma of the head and neck.

Pfister DG, Ang KK, Brizel DM, Burtness B, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Sanguineti G, Schuller DE, Shah JP, Spencer S, Trotti A 3rd, Weber RS, Wolf G, Worden F; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2012 Mar;10(3):320-38. No abstract available.

PMID:
22393194
31.

Head and neck cancers.

Pfister DG, Ang KK, Brizel DM, Burtness BA, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Sanguineti G, Schuller DE, Shah JP, Spencer S, Trotti A 3rd, Weber RS, Wolf GT, Worden F; National Comprehensive Concer Network.

J Natl Compr Canc Netw. 2011 Jun 1;9(6):596-650. Review. No abstract available. Erratum in: J Natl Compr Canc Netw. 2011 Jul;9(7):xxxiii.

PMID:
21636536
32.

The use of brachytherapy in the treatment of nonmelanoma skin cancer: a review.

Alam M, Nanda S, Mittal BB, Kim NA, Yoo S.

J Am Acad Dermatol. 2011 Aug;65(2):377-388. doi: 10.1016/j.jaad.2010.03.027. Epub 2011 Apr 15. Review.

PMID:
21496952
33.

A computational tool for the efficient analysis of dose-volume histograms from radiation therapy treatment plans.

Pyakuryal A, Myint WK, Gopalakrishnan M, Jang S, Logemann JA, Mittal BB.

J Appl Clin Med Phys. 2010 Jan 28;11(1):3013.

34.

Predictors of competing mortality in advanced head and neck cancer.

Mell LK, Dignam JJ, Salama JK, Cohen EE, Polite BN, Dandekar V, Bhate AD, Witt ME, Haraf DJ, Mittal BB, Vokes EE, Weichselbaum RR.

J Clin Oncol. 2010 Jan 1;28(1):15-20. doi: 10.1200/JCO.2008.20.9288. Epub 2009 Nov 23.

PMID:
19933920
35.

Head and neck cancers.

National Comprehensive Cancer Network, Forastiere AA, Ang KK, Brizel D, Brockstein BE, Burtness BA, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Goepfert H, Hicks WL Jr, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pfister DG, Pinto HA, Posner MR, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Trotti A 3rd, Weber RS, Wolf GT, Worden F.

J Natl Compr Canc Netw. 2008 Aug;6(7):646-95. No abstract available.

PMID:
18691457
36.

NCCN Task Force Report. prevention and management of mucositis in cancer care.

Bensinger W, Schubert M, Ang KK, Brizel D, Brown E, Eilers JG, Elting L, Mittal BB, Schattner MA, Spielberger R, Treister NS, Trotti AM 3rd.

J Natl Compr Canc Netw. 2008 Jan;6 Suppl 1:S1-21; quiz S22-4. Review.

PMID:
18289497
37.

Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients with oral cancer.

Lazarus C, Logemann JA, Pauloski BR, Rademaker AW, Helenowski IB, Vonesh EF, Maccracken E, Mittal BB, Vokes EE, Haraf DJ.

Head Neck. 2007 Jul;29(7):632-7.

PMID:
17230558
38.

High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial.

Cohen EE, Haraf DJ, List MA, Kocherginsky M, Mittal BB, Rosen F, Brockstein B, Williams R, Witt ME, Stenson KM, Kies MS, Vokes EE.

J Clin Oncol. 2006 Jul 20;24(21):3438-44.

39.

Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation.

Logemann JA, Rademaker AW, Pauloski BR, Lazarus CL, Mittal BB, Brockstein B, MacCracken E, Haraf DJ, Vokes EE, Newman LA, Liu D.

Head Neck. 2006 Jan;28(1):64-73.

40.

Head and neck cancers.

Forastiere AA, Ang K, Brizel D, Brockstein BE, Dunphy F, Eisele DW, Goepfert H, Hicks WL Jr, Kies MS, Lydiatt WM, Maghami E, McCaffrey T, Mittal BB, Pfister DG, Pinto HA, Posner MR, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Trotti A 3rd, Wheeler RH 3rd, Wolf GT, Worden F, Yueh B; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2005 May;3(3):316-91. No abstract available.

PMID:
16002004
41.

Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.

Milano MT, Vokes EE, Salama JK, Stenson KM, Kao J, Witt ME, Mittal BB, Argiris A, Weichselbaum RR, Haraf DJ.

Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1096-106.

PMID:
15752889
42.

Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck.

Milano MT, Haraf DJ, Stenson KM, Witt ME, Eng C, Mittal BB, Argiris A, Pelzer H, Kozloff MF, Vokes EE.

Clin Cancer Res. 2004 Aug 1;10(15):4922-32.

43.

Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.

Argiris A, Stenson KM, Brockstein BE, Mittal BB, Pelzer H, Kies MS, Jayaram P, Portugal L, Wenig BL, Rosen FR, Haraf DJ, Vokes EE.

Head Neck. 2004 May;26(5):447-55.

PMID:
15122662
44.

Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy.

Argiris A, Brockstein BE, Haraf DJ, Stenson KM, Mittal BB, Kies MS, Rosen FR, Jovanovic B, Vokes EE.

Clin Cancer Res. 2004 Mar 15;10(6):1956-62.

45.

Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.

Haraf DJ, Rosen FR, Stenson K, Argiris A, Mittal BB, Witt ME, Brockstein BE, List MA, Portugal L, Pelzer H, Weichselbaum RR, Vokes EE.

Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5936-43.

46.

Swallowing dysfunction--preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review.

Mittal BB, Pauloski BR, Haraf DJ, Pelzer HJ, Argiris A, Vokes EE, Rademaker A, Logemann JA.

Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1219-30. Review. No abstract available.

PMID:
14630255
47.

Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.

Rosen FR, Haraf DJ, Kies MS, Stenson K, Portugal L, List MA, Brockstein BE, Mittal BB, Rademaker AW, Witt ME, Pelzer H, Weichselbaum RR, Vokes EE.

Clin Cancer Res. 2003 May;9(5):1689-97.

48.

Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.

Vokes EE, Stenson K, Rosen FR, Kies MS, Rademaker AW, Witt ME, Brockstein BE, List MA, Fung BB, Portugal L, Mittal BB, Pelzer H, Weichselbaum RR, Haraf DJ.

J Clin Oncol. 2003 Jan 15;21(2):320-6.

PMID:
12525525
49.

Biochemical disease-free survival following adjuvant and salvage irradiation after radical prostatectomy.

Kalapurakal JA, Huang CF, Neriamparampil MM, Small WJ Jr, Pins MR, Mittal BB, Campbell SC, Grayhack JT, Shetty RM.

Int J Radiat Oncol Biol Phys. 2002 Nov 15;54(4):1047-54.

PMID:
12419430

Supplemental Content

Loading ...
Support Center